Clinical trial · Interventional
Light-Scattering Spectroscopy for Detection of Breast Cancer
Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study
NCT01755208CI-TRIAL-00055116terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insufficient Accrual
Summary
Brief summary (as posted)
This pilot clinical trial studies light-scattering spectroscopy in finding disease in patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering spectroscopy, may help find and diagnose breast cancer
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Healthy, no Evidence of Disease | — | UNRESOLVED | — |
| Stage II Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIA Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIB Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Stage IIIC Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| light-scattering spectroscopy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Diagnostic (light-scattering spectroscopy)
- description
- Patients undergo light-scattering spectroscopy of the breast in addition to standard of care as it relates to screening for breast cancer or treatment of breast cancer.
- interventionNames
- Procedure: light-scattering spectroscopy
Primary outcomes (2)
- measure
- Accurate classifications of women with or without breast cancer
- timeFrame
- Up to 1 year
- description
- Exact binomial probabilities will be used.
- measure
- Utility of optical markers in distinguishing cancer involved breasts from normal breasts
- timeFrame
- Up to 1 year
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Participants who are breast cancer free (mammogram "negative" within 1 month of testing) with the absence of clinical suspicion of breast cancer on physical exam or with clinical stage II or stage III breast cancer. PLEASE NOTE: Recruitment for this study is only limited to patients who are scheduled for a mammogram at USC. There is no compensation to participants. * Provision of informed consent prior to any study-related procedures Exclusion Criteria: * Females with tattoos on either or both breasts * Females with nipple piercings on either or both breasts * Females with skin piercings (aka microdermal anchor surface or microdermal piercings) in either or both breasts * Females unable to provide informed consent * Females s/p treatment for breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.